Sector : Pharmaceuticals and health care | Smallcap | BSE
Date Time | Announcment |
|---|---|
| May 06, 2026, 10:27 PM IST | Venmax Drugs&Pharma. - Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Y |
| Apr 14, 2026, 10:00 PM IST | Venmax Drugs&Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 14, 2026, 6:06 AM IST | Venmax Drugs&Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 06, 2026, 5:34 AM IST | Venmax Drugs&Pharma. - Regulation 31(4) - SAST Disclosure |
| Mar 30, 2026, 10:42 PM IST | Venmax Drugs&Pharma. - Announcement under Regulation 30 (LODR)-Change in Management |
| Mar 27, 2026, 9:39 PM IST | Venmax Drugs&Pharma. - Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation |
| Mar 23, 2026, 9:24 PM IST | Venmax Drugs&Pharma. - Announcement under Regulation 30 (LODR)-Allotment |
| Feb 08, 2026, 12:04 AM IST | Venmax Drugs&Pharma. - Statement Of Deviation And Variation For The Quarter Ended December 31, 2025. |
| Feb 07, 2026, 11:26 PM IST | Venmax Drugs&Pharma. - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. |
| Feb 07, 2026, 11:16 PM IST | Venmax Drugs&Pharma. - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 3 |
1 of 9 pages
✕
Market Pulse